Evertec (NYSE:EVTC) reported quarterly earnings of $0.65 per share which met the analyst consensus estimate. This is a 16.67 percent decrease over earnings of $0.78 per share from the same period last year. The company reported quarterly sales of $160.57 million which beat the analyst consensus estimate of $151.79 million by 5.78 percent. This is a 7.66 percent increase over sales of $149.15 million the same period last year.
Evertec Q2 EPS $0.65, Inline, Sales $160.57M Beat $151.79M Estimate
Evertec (NYSE:EVTC) reported quarterly earnings of $0.65 per share which met the analyst consensus estimate. This is a 16.67 percent decrease over earnings of $0.78 per share from the same period last year. The company
Related Posts
First Bancorp Q4 EPS $0.71 Down From $0.8 YoY
First Bancorp (NASDAQ:FBNC) reported quarterly earnings of $0.71 per share. This is a 11.25 percent decrease over earnings…
Altamira Therapeutics Reports Approval Of Bentrio Nasal Spray In Malaysia
Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics announced today that
Raymond James Maintains Strong Buy on M.D.C. Holdings, Lowers Price Target to $79
Raymond James analyst Buck Horne maintains M.D.C. Holdings (NYSE:MDC) with a Strong Buy and lowers the price target from $80 to $79.